WT1 and acute myeloid leukemia: In addition, the WT1-CTLs did not demonstrate significant cytotoxicity against either allogeneic or autologous normal donor PBMCs at an E:T ratio of 5, suggesting that killing of the AML cell lines is not mediated merely by HLA-mismatch or a mixed lymphocyte reaction (Fig. 1E).